Deleted Tweets From Scott Gottlieb, R-D.C.

We're hopeful this scientific workshop will provide valuable information and input that #FDA can use to further address e-cigarette use among youth and help those who may already be addicted to these products through potential new therapies.

RT @FDAOncology: Public workshop on #tissueagnostic drug development. Watch online or join us in person. https://t.co/GzGx6RQhnF

We’re continuing to see products labeled as homeopathic being marketed without #FDA approval for a wide array of diseases and conditions, from chronic pain to cancer. Some of these products may not deliver any benefit and might cause harm.

We’ve committed to taking continued actions to protect public health when we believe patients are being put at risk by homeopathic products that contain potentially harmful ingredients or have significant quality issues.

Today, we’ve taken enforcement action against homeopathic drug manufacturers who continue to put patients at risk for significant quality issues and for marketing to consumers without #FDA approval. https://t.co/VJJxEii8wV https://t.co/XHtZxNuIDi

RT @FDA_Track: FDA warns #homeopathic firms for putting patients at risk with significant violations of manufacturing quality standards https://t.co/jRNSz0d9Qj

RT @US_FDA: FDA will hold a scientific workshop on May 15 to gather information on strategies to help youth quit using tobacco,… https://t.co/vfU8m6EoWi

RT @FDAJobs: �FDA’s Office of Regulatory Affairs throughout the US including Puerto Rico and the US Virgin Islands. #FDA https://t.co/7h214SY36q

RT @FDATobacco: #DYK from 2017 to 2018, current e-cigarette use increased alarmingly from 2.1 million to 3.6 million among middle a… https://t.co/1XKH1peo2G

RT @AppropsDems: Also at 9am on Wednesday - @US_FDA Commissioner @SGottliebFDA testifies before the Agriculture-Rural Development-FD… https://t.co/XkaAo38TtD

RT @FDAfood: No #AprilFools here - calories from beverages can quickly add up. With calorie information, you can find lower-calo… https://t.co/Cjwh5rwpV6

RT @jeff_cranmer: Bioinformatics pioneer & Principal Deputy @US_FDA Commissioner Amy Abernethy named acting chief information officer… https://t.co/XCzBA8RkBF

THREAD: #FDA is announcing a funding opportunity that’ll help target and define durations of use for certain medically important antimicrobial drugs in the feed of food-producing animals. The grants may provide up to $1.5M https://t.co/uFAkC0S7HC

@angelicalavito And here it is: our #FDA sanctioned device for keeping jellybeans free from pathogens. https://t.co/eyMDZDQvft

RT @FDAWomen: The FDA Office of Women’s Health offers free health resources in more than 15 languages! This National Minority Health Month, share these resources with the women in your community: https://t.co/Mj3jpbkppx #NMHM19 https://t.co/9ITXmtlwZw

Defining more targeted durations of use supports our ongoing efforts to slow the development of antimicrobial resistance and helps preserve the effectiveness of these antimicrobials in both veterinary and human medicine. Learn how to apply here: https://t.co/Zmnc1LK9jU

The #FDA will be finalizing our homeopathy guidance soon, outlining our risk based approach to enforcement. We’re increasingly concerned by a proliferation of homeopathy products that don’t offer any demonstrated benefits and create risks to consumers. https://t.co/lCLQDGUfk6

RT @FDAMedia: Statement from FDA Commissioner @SGottliebFDA, on the agency’s continued efforts to bring competition to the insulin market to lower prices and expand access https://t.co/1D9PnxKi48

The aim is to help generate publicly available data that sponsors of affected approved animal drug applications can use to update product dosage regimens to better target when and for how long their drugs may be used.

Today #FDA announced a number of important new steps and actions to advance our consideration of a framework for the lawful marketing of appropriate cannabis and cannabis-derived products under our existing authorities: https://t.co/G51zmEqvr3 https://t.co/BrhAjtKrBu

We're hopeful this scientific workshop will provide valuable information and input that #FDA can use to further address e-cigarette use among youth and help those who may already be addicted to these products through potential new therapies.

RT @FDAOncology: Public workshop on #tissueagnostic drug development. Watch online or join us in person. https://t.co/GzGx6RQhnF

We’re continuing to see products labeled as homeopathic being marketed without #FDA approval for a wide array of diseases and conditions, from chronic pain to cancer. Some of these products may not deliver any benefit and might cause harm.

We’ve committed to taking continued actions to protect public health when we believe patients are being put at risk by homeopathic products that contain potentially harmful ingredients or have significant quality issues.

Today, we’ve taken enforcement action against homeopathic drug manufacturers who continue to put patients at risk for significant quality issues and for marketing to consumers without #FDA approval. https://t.co/VJJxEii8wV https://t.co/XHtZxNuIDi

RT @FDA_Track: FDA warns #homeopathic firms for putting patients at risk with significant violations of manufacturing quality standards https://t.co/jRNSz0d9Qj

RT @US_FDA: FDA will hold a scientific workshop on May 15 to gather information on strategies to help youth quit using tobacco,… https://t.co/vfU8m6EoWi

RT @FDAJobs: �FDA’s Office of Regulatory Affairs throughout the US including Puerto Rico and the US Virgin Islands. #FDA https://t.co/7h214SY36q

RT @FDATobacco: #DYK from 2017 to 2018, current e-cigarette use increased alarmingly from 2.1 million to 3.6 million among middle a… https://t.co/1XKH1peo2G

RT @AppropsDems: Also at 9am on Wednesday - @US_FDA Commissioner @SGottliebFDA testifies before the Agriculture-Rural Development-FD… https://t.co/XkaAo38TtD

RT @FDAfood: No #AprilFools here - calories from beverages can quickly add up. With calorie information, you can find lower-calo… https://t.co/Cjwh5rwpV6

RT @jeff_cranmer: Bioinformatics pioneer & Principal Deputy @US_FDA Commissioner Amy Abernethy named acting chief information officer… https://t.co/XCzBA8RkBF

THREAD: #FDA is announcing a funding opportunity that’ll help target and define durations of use for certain medically important antimicrobial drugs in the feed of food-producing animals. The grants may provide up to $1.5M https://t.co/uFAkC0S7HC

@angelicalavito And here it is: our #FDA sanctioned device for keeping jellybeans free from pathogens. https://t.co/eyMDZDQvft

RT @FDAWomen: The FDA Office of Women’s Health offers free health resources in more than 15 languages! This National Minority Health Month, share these resources with the women in your community: https://t.co/Mj3jpbkppx #NMHM19 https://t.co/9ITXmtlwZw

Defining more targeted durations of use supports our ongoing efforts to slow the development of antimicrobial resistance and helps preserve the effectiveness of these antimicrobials in both veterinary and human medicine. Learn how to apply here: https://t.co/Zmnc1LK9jU

The #FDA will be finalizing our homeopathy guidance soon, outlining our risk based approach to enforcement. We’re increasingly concerned by a proliferation of homeopathy products that don’t offer any demonstrated benefits and create risks to consumers. https://t.co/lCLQDGUfk6

RT @FDAMedia: Statement from FDA Commissioner @SGottliebFDA, on the agency’s continued efforts to bring competition to the insulin market to lower prices and expand access https://t.co/1D9PnxKi48

The aim is to help generate publicly available data that sponsors of affected approved animal drug applications can use to update product dosage regimens to better target when and for how long their drugs may be used.

Today #FDA announced a number of important new steps and actions to advance our consideration of a framework for the lawful marketing of appropriate cannabis and cannabis-derived products under our existing authorities: https://t.co/G51zmEqvr3 https://t.co/BrhAjtKrBu